A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 129.36
GOOG 573.64
MSFT 43.28
FB 79.60
BAC 16.04

Recently Added

LXK 41.21
WNRL 30.36
TMUS 32.76
HART 4.14
CVA 21.67

Gaining Speed

LXK 41.21
WNRL 30.36
FDX 176.15
TMUS 32.76
GEN 7.10

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!